Changes in Work Productivity and Interictal Burden: Results from a Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Galcanezumab in Adults with Treatment-Resistant Migraine (CONQUER) (700)
-
- David Garcia-Azorin
- Hospital Clínico Universitario de Valladolid
-
- Janet Ford
- Eli Lilly and Company
-
- Dawn Buse
- Albert Einstein College of Medicine
-
- Austin Hand
- IQVIA
-
- Linda Wietecha
- Eli Lilly and Company
-
- Holland Detke
- Eli Lilly and Company
書誌事項
- 公開日
- 2020-04-14
- DOI
-
- 10.1212/wnl.94.15_supplement.700
- 公開者
- Ovid Technologies (Wolters Kluwer Health)
この論文をさがす
収録刊行物
-
- Neurology
-
Neurology 94 (15_supplement), 2020-04-14
Ovid Technologies (Wolters Kluwer Health)
